Back to Search Start Over

T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression.

Authors :
Yazdani S
Seitz C
Cui C
Lovik A
Pan L
Piehl F
Pawitan Y
Kläppe U
Press R
Samuelsson K
Yin L
Vu TN
Joly AL
Westerberg LS
Evertsson B
Ingre C
Andersson J
Fang F
Source :
Nature communications [Nat Commun] 2022 Nov 08; Vol. 13 (1), pp. 6733. Date of Electronic Publication: 2022 Nov 08.
Publication Year :
2022

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, involving neuroinflammation and T cell infiltration in the central nervous system. However, the contribution of T cell responses to the pathology of the disease is not fully understood. Here we show, by flow cytometric analysis of blood and cerebrospinal fluid (CSF) samples of a cohort of 89 newly diagnosed ALS patients in Stockholm, Sweden, that T cell phenotypes at the time of diagnosis are good predictors of disease outcome. High frequency of CD4 <superscript>+</superscript> FOXP3 <superscript>-</superscript> effector T cells in blood and CSF is associated with poor survival, whereas high frequency of activated regulatory T (Treg) cells and high ratio between activated and resting Treg cells in blood are associated with better survival. Besides survival, phenotypic profiling of T cells could also predict disease progression rate. Single cell transcriptomics analysis of CSF samples shows clonally expanded CD4 <superscript>+</superscript> and CD8 <superscript>+</superscript> T cells in CSF, with characteristic gene expression patterns. In summary, T cell responses associate with and likely contribute to disease progression in ALS, supporting modulation of adaptive immunity as a viable therapeutic option.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
13
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
36347843
Full Text :
https://doi.org/10.1038/s41467-022-34526-9